# Randomized Trial for Pharmacogenomics-based Tuberculosis Therapy (RT-PGTT)

> **NCT00298870** · PHASE4 · COMPLETED · sponsor: **Osaka University** · enrollment: 172 (actual)

## Conditions studied

- Pulmonary Tuberculosis

## Interventions

- **DRUG:** Isoniazid
- **DRUG:** isoniazed

## Key facts

- **NCT ID:** NCT00298870
- **Lead sponsor:** Osaka University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 172 (ACTUAL)
- **Last updated:** 2012-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00298870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00298870, "Randomized Trial for Pharmacogenomics-based Tuberculosis Therapy (RT-PGTT)". Retrieved via AI Analytics 2026-08-20 from https://api.ai-analytics.org/clinical/NCT00298870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*